
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight Inc. is positioned for sustained double-digit growth due to increasing utilization rates within its expanding light adjustable lens (LDD) installed base. The company's financial outlook benefits from potential upside drivers, including accelerated growth in the LDD installed base, higher laser-assisted lenses (LAL) volumes, and improved profit margins. Furthermore, as LALs constitute a larger portion of total revenue, cash burn is expected to decrease, enhancing overall financial stability.
Bears say
RxSight Inc faces significant risks that could adversely impact its financial outlook, including limited adoption of its intraocular lens technology due to the necessity for additional capital equipment. Furthermore, the company is confronting challenges related to disappointing commercial execution and increased competition within the intraocular lens market. As a consequence, projected revenues for 2025 and 2026 have been revised downward to $164 million and $205 million, respectively, reflecting a loss of confidence in future performance.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares